News
Stay up to date with Sintetica’s latest news.
We are pleased to announce that Dr. Hubert Puech d'Alissac has been appointed Executive Chairman of the Board and CEO of Sintetica.
Along his diverse career path, Dr. Puech d'Alissac has held positions of high responsibility in Europe, Africa, Asia and North America. His extensive knowledge and proven track record enable him to bring a broad strategic vision and considerable operational capabilities to Sintetica…
Sintetica US launches Lidocaine Hydrochloride Injection, USP 1%, 2% and 4%
Lidocaine hydrochloride is a short-acting amide-type local anesthetic with a rapid onset and short duration of action and contains no preservatives.